The global roadside drug testing devices market size is predicted to be worth around US$ 1.2 billion by 2030, according to new report study.
The global roadside drug testing devices market size was valued at US$ 700 Mn in 2020 and is expected to expand at a CAGR of 4.5% from 2021 to 2030.
The roadside drug testing devices market is projected for exponential growth in North America. Lack of efficient DUI laws in the U.S. are fueling the demand for drug testing devices. Manufacturers are increasing efforts to meet the demand for breath analyzers that can detect extremely low quantities of THC analytes.
Increased research spending has become the key focus point of companies in the market landscape. However, incidences of false positives from poppy seeds and tea in drug testing devices act as barriers for market growth. Hence, manufacturers should develop devices that can differentiate between drugs or alcohol and food items that are merely in the system of an individual.
A Key Driver
Driving Simulators Help in Conducting Successful Clinical Trials
As suggested by the Swinburne University of Technology, drug users are apparently surpassing the number of alcohol consumers in Australia, resulting in high rates of fatal crashes. Hence, companies in the roadside drug testing devices market should tap opportunities in Australia to increase the uptake of detection devices. Likewise, companies in the market for roadside drug testing devices are collaborating with researchers to increase R&D in psychology and neurosciences to ascertain if drivers under the influence of cannabis are more likely to meet with an accident, as compared to alcohol consumers.
With the introduction of driving simulators, companies in the roadside drug testing devices market are able to conduct better analysis of cognitive behavior and psychomotor functioning of individuals through the help of clinical trials. Companies in the market for roadside drug testing devices are gaining important insights through research findings carried out as a result of collaborations between universities and medical institutes.
Breathalyzers with Nanotechnology Sensors a Gold Standard for Detection of THC
Breathalyzers are becoming increasingly mainstream in the detection of alcohol in the roadside drug testing devices market. However, there is a growing need for breathalyzers that are also capable of detecting marijuana. Hence, researchers in the market for roadside drug testing devices are increasing R&D to develop novel breathalyzers that detect THC. For instance, an interdisciplinary team at the University of Pittsburgh, developed a breathalyzer using nanotechnology sensors that detect THC. Thus, innovative breathalyzers are increasingly becoming the gold standard for THC detection and manufacturers should collaborate with researchers to innovate in devices. This trend has supported the exponential growth of THC among other substance types in the roadside drug testing devices market.
Companies in the roadside drug testing devices market are increasing research in developing breathalyzers using carbon nanotubes and nanotechnology sensors to meet requirements of mass spectrometry. This trend is prominent in the U.S. since legalization of recreational marijuana has raised concerns about the enforcement of DUI (Driving Under the Influence) laws in the region.
Stringent Law Enforcement to Drive Adoption of Advanced Roadside Drug Testing Devices
Drug-impaired driving has emerged as a major public health issue. Alcohol and psychoactive drugs affect an individual’s ability to drive a motor vehicle safely. Increase in number of drug and alcohol abusers across the world presents significant opportunities for the test providers and manufacturers of drug abuse test products. According to the National Institute of Drug Abuse, alcohol, tobacco, and illicit drugs create an economic burden of nearly US$ 740 Bn in the U.S. in terms of related costs, lost work productivity, and healthcare. Technological advancements related to sample collection and efforts of manufacturers to create easy-to-use disposable test kits are expected to increase the demand for drug abuse testing products. Manufacturers focus on using samples other than urine such as sweat and hair, which are less embarrassing for individuals tested for drug abuse. Manufacturers also focus on development of rapid tests that provide faster results, are easy to use, and affordable compared to the tests conducted in laboratories.
Large Target Population
Inaccurate Results to Hamper Roadside Drug Testing Devices Market
Devices for Testing Alcohol Abuse to Witness High Demand
In terms of substance, the alcohol segment held major share of the global roadside drug testing devices market in 2020. The segment is projected to dominate the global market during the forecast period. The alcohol segment is anticipated to expand at a CAGR of 4.3% from 2021 to 2030. Rise in consumption of alcohol and increase in incidence of driving under the influence of alcohol accelerate the growth of the global roadside drug testing devices market. Moreover, increase in approvals of roadside drug testing devices and rise in the impact of alcohol abuse on public health contribute to the growth of the global market.
Breath Analyzers to Lead Global Market
Based on sample type, the others segment, which includes breath, hair, and blood, accounted for significant share of the global roadside drug testing devices market in 2020. The segment is expected to expand at a moderate CAGR during the forecast period. Breath is the most common sample used for the detection of alcohol. Alcohol is the most widely used substance of abuse among drivers. According to data provided by the European DRUID project, alcohol is used by 3.48% drivers, illicit drugs by 1.90%, medicinal drugs by 1.36%, drug-drug combination by 0.39%, and alcohol-drug combination by 0.37%. The saliva segment is likely to witness strong growth during the forecast period. Roadside oral fluid or saliva testing is primarily being used in several countries to detect the presence of drugs. Countries such as Germany, Belgium, France, and Australia use saliva testing for identification of individuals driving under the influence of drugs (DUID).
North America held major share of the global roadside drug testing devices market in 2020. The market in the region is driven by presence of key players, high prevalence of driving under the influence of alcohol & illicit drugs, and growth strategies adopted by market players, including product approvals and launch, mergers, and acquisitions. According to Centers for Disease Control and Prevention (CDC) estimates, around 20.5 million people in the U.S. were reported driving under the influence of alcohol in 2020. Europe held the second largest share of the global roadside drug testing devices market in 2020. Growth of the roadside drug testing devices market in the region can be attributed to rise in cases of driving under the influence of alcohol and increase in government initiatives to control road accidents & fatalities in various countries in Europe. Asia Pacific accounted for significant share of the global roadside drug testing devices market in 2020. The market in the region is projected to grow at a rapid pace during the forecast period. According to various studies, alcohol consumption is rising across Asia Pacific. Heavy episodic (binge) alcohol use has increased significantly in China, Thailand, Timor-Leste, and Vietnam. Rise in use of alcohol and other illicit drugs in the region is anticipated to drive the market in Asia Pacific during the forecast period. Moreover, implementation of strict driving laws in different countries in Asia Pacific can be attributed to the growth of the market in the region.
Prominent players operating in the global roadside drug testing devices market are Drägerwerk AG & Co. KgaA, Abbott Laboratories, Oranoxis, Inc., CareHealth America, MAVAND Solutions GmbH, Pacific Data Systems Pty Ltd., Securetec, and UriTox, LLC.
By Sample Type
Cancer Immunotherapy Market (By Product: Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines; By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer, Pancreatic Cancer) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Women’s Health App Market (By Type: Fitness & Nutrition, Menstrual Health, Pregnancy Tracking & Postpartum Care, Menopause, Disease Management) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Biopharmaceutical Third Party Logistics Market (By Supply Chain: Cold Chain, Non-cold Chain; By Service Type: Transportation, Warehousing and Storage) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Traumatic Brain Injury Assessment & Management Devices Market (By Device: Imaging Devices, Monitoring Devices; By Technique: Intracranial Pressure (ICP) Monitoring, Partial Pressure of Oxygen in Brain Tissue (pBrO2); By End-use: Hospitals, Diagnostic Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Magnetic Resonance Imaging Market (By Architecture: Closed System, Open System; By Field Strength: Low Field Strength, Mid Field Strength, High Field Strength; By Application: Brain and neurological, Spine and musculoskeletal, Vascular, Abdominal, Cardiac, Breast; By End-use: Hospitals, Imaging Centers, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...